Clorox (NYSE:CLX) PT Lowered to $132.00 at Barclays

Clorox (NYSE:CLX) had its target price decreased by Barclays from $136.00 to $132.00 in a report released on Thursday morning, Benzinga reports. Barclays currently has an underweight rating on the stock.

Several other equities analysts have also recently issued reports on CLX. Citigroup decreased their price objective on Clorox from $155.00 to $150.00 and set a neutral rating for the company in a report on Wednesday, May 1st. Jefferies Financial Group upgraded Clorox from an underperform rating to a hold rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Morgan Stanley restated an equal weight rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $159.00 to $158.00 and set a neutral rating for the company in a research report on Wednesday, May 1st. Finally, UBS Group dropped their target price on Clorox from $164.00 to $159.00 and set a neutral rating on the stock in a research report on Wednesday, May 1st. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Hold and an average price target of $146.43.

Clorox Price Performance

Shares of NYSE CLX opened at $138.23 on Thursday. Clorox has a 52 week low of $114.68 and a 52 week high of $176.24. The company has a quick ratio of 0.57, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The firm has a market cap of $17.17 billion, a P/E ratio of 71.62, a P/E/G ratio of 2.16 and a beta of 0.44. The business’s 50 day moving average price is $148.45 and its 200 day moving average price is $143.43.

Clorox (NYSE:CLX) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.51 earnings per share. On average, sell-side analysts expect that Clorox will post 5.83 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.47%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 248.71%.

Institutional Trading of Clorox

Large investors have recently bought and sold shares of the business. Fortitude Family Office LLC acquired a new position in shares of Clorox during the 4th quarter worth approximately $29,000. Venturi Wealth Management LLC lifted its holdings in Clorox by 308.5% in the first quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after acquiring an additional 145 shares during the last quarter. Northwest Financial Advisors purchased a new position in Clorox during the fourth quarter worth about $29,000. Core Wealth Advisors Inc. purchased a new stake in shares of Clorox in the 4th quarter valued at approximately $29,000. Finally, First United Bank & Trust acquired a new position in shares of Clorox in the 4th quarter worth approximately $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.